Evan R. Goldfischer, MD, MBA

Evan R. Goldfischer, MD, MBA, FACS

Premier Medical Group

Poughkeepsie, New York

Evan R. Goldfischer, MD, MBA, FACS, is a urologist and Director of the Research Department at Premier Medical Group in Poughkeepsie, New York. He received his BA from Tufts University and his MD from Cornell University Medical College. He completed his internship in general surgery and his residency in urology at the University of Chicago. He then completed a fellowship in endourology under the direction of Arthur Smith at Long Island Jewish Medical Center. Dr. Goldfischer received his MBA from the University of Massachusetts and is a certified physician executive. He is the founder and chair of the Board of Premier Cares Foundation, which aims to support and educate individuals who are unable to address significant issues like prostate and colon cancer. He has authored more than 100 peer-reviewed abstracts and publications and has lectured on six continents. Dr. Goldfischer has served as the chair of the Advanced Prostate Cancer Expert Panel for the Public Education Council of the Urology Care Foundation, which is the official foundation of the AUA. He was elected to the LUGPA Board of Directors in 2014 and was elected secretary of LUGPA in November 2018. Dr. Goldfischer was elected president of LUGPA in 2022 and still serves in that role.

Talks by Evan R. Goldfischer, MD, MBA, FACS

Managing a Clinical Research Program in 2020 (Updated)

Evan R. Goldfischer, MD, MBA, FACS | Jul 2020

Evan R. Goldfischer, MD, MBA, CPI, CPE, Co-Founding CEO and Founding Director of Research for Premier Medical Group of the Hudson Valley, and Secretary of LUGPA, details how to effectively manage a clinical research program. He examines why clinical research is important and how it has changed over the years, with the biggest changes in 2020 being more training, more paperwork, and more time and difficulty negotiating budgets. Dr. Goldfischer discusses the importance of integrating the research program with the cancer clinic, as well as how the staff must work together to ensure a program’s success. He stresses the importance of clinical research involving everyone in the practice. In a follow-up Q&A with E. David Crawford, MD, Dr. Goldfischer discusses practical changes to research brought on by COVID-19.

Managing a Clinical Research Program in 2020

Evan R. Goldfischer, MD, MBA, FACS | Apr 2020

Evan R. Goldfischer, MD, MBA, Co-Founding CEO and Founding Director of Research for Premier Medical Group of the Hudson Valley, discusses how those managing clinical research programs must adapt to new pressures in 2020. He notes that the increases in regulation and FDA oversight are challenges. He also details the necessary structure of research departments and processes for budget negotiation. By also describing possible pitfalls of clinical research programs, Dr. Goldfischer gives an encompassing overview of the process of clinical research program management.

Increased Telemedicine Usage in Urology Amidst COVID-19 Pandemic

Evan R. Goldfischer, MD, MBA, FACS | Mar 2020

Evan R. Goldfischer, MD, MBA, Co-Founding CEO and Founding Director of Research for Premier Medical Group of the Hudson Valley, discusses how the COVID-19 pandemic has impacted telemedicine in urology. He examines how the recent need to keep as many patients out of the office as possible has accelerated the uptake of telemedicine in many practices and led to insurance companies relaxing regulations on its use. Dr. Goldfischer details the importance of choosing a good platform and overcoming technical challenges for older patients, including assigning a telemedicine manager. He further outlines the different types of telehealth consultations, from a quick check-in to a full visit, as well as requirements for visit time and A/V connections. Dr. Goldfischer concludes with information about billing and coding telehealth visits and how urologists can be properly reimbursed.

Negotiating Hospital Contracts

Evan R. Goldfischer, MD, MBA, FACS | Apr 2018

Evan R. Goldfischer, MD, MBA, FACS, advises urologists on how to optimally and responsibly negotiate hospital contracts under present-day Fair Market Value parameters. He describes negotiating service arrangements, clinical co-management, call coverage, and quality improvement programs.